GenapSys, the developer of a genomic diagnostic system, has raised $8.49 million of a planned $13.57 million round from Nazem & Co. and Bay City Capital, according to an SEC filing. The Redwood City, CA-based company was founded by Dr. Hesaam Esfandyarpour who conceived a method for DNA Sequencing centered around a pure electronic chip which detects the main reaction in a simple, low-cost fashion. GenapSys, which came out of Stanford’s StartX program, was also awarded a $4 million grant from the National Human Genome Research Institute in September 2012.
